ERBB2 and neoplasm: We found no relationship between E-cad expression and LVI and BVI, as well as histologic grade and type and other immunohistochemical features of the primary tumor (ER, PR, Ki67, p53, and Her2/neu expressions), confirming results of other studies [39].